Arikawa-Hirasawa E - Search Results

1

Atherosclerosis in perlecan heterozygous mice.

Vikramadithyan RK, Kako Y, Chen G, Hu Y, Arikawa-Hirasawa E, Yamada Y, Goldberg IJ. Vikramadithyan RK, et al. J Lipid Res. 2004 Oct;45(10):1806-12. doi: 10.1194/jlr.M400019-JLR200. Epub 2004 Jul 16. J Lipid Res. 2004. PMID: 15258195 Free article.

2

Role of perlecan in skeletal development and diseases.

Hassell J, Yamada Y, Arikawa-Hirasawa E. Hassell J, et al. Glycoconj J. 2002 May-Jun;19(4-5):263-7. doi: 10.1023/A:1025340215261. Glycoconj J. 2002. PMID: 12975604 Review.

3

[Roles of perlecan in development and disease: studies in knockout mice and human disorders].

Arikawa-Hirasawa E, Yamada Y. Arikawa-Hirasawa E, et al. Seikagaku. 2001 Oct;73(10):1257-61. Seikagaku. 2001. PMID: 11725543 Review. Japanese. No abstract available.

4

Absence of acetylcholinesterase at the neuromuscular junctions of perlecan-null mice.

Arikawa-Hirasawa E, Rossi SG, Rotundo RL, Yamada Y. Arikawa-Hirasawa E, et al. Nat Neurosci. 2002 Feb;5(2):119-23. doi: 10.1038/nn801. Nat Neurosci. 2002. PMID: 11802174

5

Dyssegmental dysplasia, Silverman-Handmaker type: unexpected role of perlecan in cartilage development.

Arikawa-Hirasawa E, Wilcox WR, Yamada Y. Arikawa-Hirasawa E, et al. Am J Med Genet. 2001 Winter;106(4):254-7. doi: 10.1002/ajmg.10229. Am J Med Genet. 2001. PMID: 11891676 Review.

6

Perlecan is required for the chondrogenic differentiation of synovial mesenchymal cells through regulation of Sox9 gene expression.

Sadatsuki R, Kaneko H, Kinoshita M, Futami I, Nonaka R, Culley KL, Otero M, Hada S, Goldring MB, Yamada Y, Kaneko K, Arikawa-Hirasawa E, Ishijima M. Sadatsuki R, et al. J Orthop Res. 2017 Apr;35(4):837-846. doi: 10.1002/jor.23318. Epub 2016 Jun 15. J Orthop Res. 2017. PMID: 27238423 Free article.

7

Perlecan deficiency causes muscle hypertrophy, a decrease in myostatin expression, and changes in muscle fiber composition.

Xu Z, Ichikawa N, Kosaki K, Yamada Y, Sasaki T, Sakai LY, Kurosawa H, Hattori N, Arikawa-Hirasawa E. Xu Z, et al. Matrix Biol. 2010 Jul;29(6):461-70. doi: 10.1016/j.matbio.2010.06.001. Epub 2010 Jun 9. Matrix Biol. 2010. PMID: 20541011 Free PMC article.

8

Perlecan is essential for cartilage and cephalic development.

Arikawa-Hirasawa E, Watanabe H, Takami H, Hassell JR, Yamada Y. Arikawa-Hirasawa E, et al. Nat Genet. 1999 Nov;23(3):354-8. doi: 10.1038/15537. Nat Genet. 1999. PMID: 10545953

9

Dyssegmental dysplasia, Silverman-Handmaker type, is caused by functional null mutations of the perlecan gene.

Arikawa-Hirasawa E, Wilcox WR, Le AH, Silverman N, Govindraj P, Hassell JR, Yamada Y. Arikawa-Hirasawa E, et al. Nat Genet. 2001 Apr;27(4):431-4. doi: 10.1038/86941. Nat Genet. 2001. PMID: 11279527

10

Perlecan regulates pericyte dynamics in the maintenance and repair of the blood-brain barrier.

Nakamura K, Ikeuchi T, Nara K, Rhodes CS, Zhang P, Chiba Y, Kazuno S, Miura Y, Ago T, Arikawa-Hirasawa E, Mukouyama YS, Yamada Y. Nakamura K, et al. J Cell Biol. 2019 Oct 7;218(10):3506-3525. doi: 10.1083/jcb.201807178. Epub 2019 Sep 20. J Cell Biol. 2019. PMID: 31541017 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

74 results

Search Page

Filters